This department is offering the Clinical Trials in Organ Transplantation in Children and Adults (CTOT-CA) grant to improve the long-term outcome of adult and pediatric transplant recipients. The grant supports cooperative, multi-institutional consortia for interventional trials or observational clinical studies in organ, vascularized composite tissue, or cellular replacement allotransplantation. Each applicant institution must represent a consortium of 2 or more clinical sites and include mechanistic studies focusing on immune-mediated processes. The goal is to enhance understanding and reduce immune- and infection-mediated morbidity and mortality of allotransplantation. Closing date: Oct 09, 2020.
Opportunity ID: 326342
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | RFA-AI-20-029 |
| Funding Opportunity Title: | Clinical Trials in Organ Transplantation in Children and Adults (CTOT-CA) (U01 Clinical Trial Optional) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement |
| Category of Funding Activity: | Health |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.855 — Allergy and Infectious Diseases Research |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Apr 15, 2020 |
| Last Updated Date: | Apr 15, 2020 |
| Original Closing Date for Applications: | Oct 09, 2020 |
| Current Closing Date for Applications: | Oct 09, 2020 |
| Archive Date: | Nov 14, 2020 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | – |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Others (see text field entitled “Additional Information on Eligibility” for clarification) Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Native American tribal governments (Federally recognized) Independent school districts Native American tribal organizations (other than Federally recognized tribal governments) Public and State controlled institutions of higher education Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Public housing authorities/Indian housing authorities County governments Special district governments For profit organizations other than small businesses Small businesses State governments City or township governments Private institutions of higher education |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | The purpose of this FOA is to solicit applications to participate in a clinical studies program to improve the long-term outcome of adult and pediatric transplant recipients (thoracic organ, abdominal organ, vascular composite tissue, and cellular replacement). The Clinical Trials in Organ Transplantation in Children and Adults (CTOT-CA) program will support cooperative, multi-institutional consortia for the conduct of interventional trials (Phase 1, 2, or 3) or observational clinical studies in organ, vascularized composite tissue, or cellular replacement allotransplantation. Each applicant institution must represent a consortium of 2 or more clinical sites. Each clinical study must include associated mechanistic studies that focus on immune-mediated processes that are relevant to the proposed clinical study. The goals of this research will be to further our understanding of and ultimately reduce immune- and infection-mediated morbidity and mortality of allotransplantation. |
| Link to Additional Information: | http://grants.nih.gov/grants/guide/rfa-files/RFA-AI-20-029.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV Email:FBOWebmaster@OD.NIH.GOV |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
There are no related documents on this grant.
Packages
| Agency Contact Information: | NIH OER Webmaster FBOWebmaster@OD.NIH.GOV Email: FBOWebmaster@OD.NIH.GOV |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| FORMS-F | Use for due dates on or after May 25, 2020 | PKG00261058 | Sep 09, 2020 | Oct 09, 2020 | View |
Package 1
Mandatory forms
326342 RR_SF424_2_0-2.0.pdf
326342 PHS398_CoverPageSupplement_5_0-5.0.pdf
326342 RR_OtherProjectInfo_1_4-1.4.pdf
326342 PerformanceSite_2_0-2.0.pdf
326342 RR_KeyPersonExpanded_2_0-2.0.pdf
326342 RR_Budget10_1_4-1.4.pdf
326342 PHS398_ResearchPlan_4_0-4.0.pdf
326342 PHSHumanSubjectsAndClinicalTrialsInfo_2_0-2.0.pdf
Optional forms
326342 RR_SubawardBudget10_30_1_4-1.4.pdf
326342 PHS_AssignmentRequestForm_3_0-3.0.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
